Breaking News Instant updates and real-time market news.

AMAG

Amag Pharmaceuticals

$20.70

(0.00%)

04:55
07/11/18
07/11
04:55
07/11/18
04:55

Amag Pharmaceuticals management to meet with Jefferies

Meetings to be held in New York on July 10 and in Boston on July 11 hosted by Jefferies.

  • 11

    Jul

  • 23

    Mar

AMAG Amag Pharmaceuticals
$20.70

(0.00%)

06/15/18
06/15/18
DOWNGRADE
Target $20

Neutral
Amag downgraded to Neutral from Buy at Janney Montgomery Scott
As previously reported, Janney Montgomery Scott analyst Ken Trbovich downgraded Amag Pharmaceuticals to Neutral from Buy after the company announced it has agreed to divest Cord Blood Registry to a private equity investment firm for $530M in cash. The sale loses a positive contributor for the company at a price below which CBR was acquired, said Trbovich, who maintains a $20 fair value estimate on Amag shares, which are down about 5% to $23.60 in morning trading.
06/15/18
RILY
06/15/18
UPGRADE
RILY
Buy
Amag Pharmaceuticals upgraded to Buy from Neutral at B. Riley FBR
06/15/18
06/15/18
UPGRADE
Target $30

Buy
Amag Pharmaceuticals upgraded to Buy after deal to sell CBR at B. Riley FBR
As previously reported, B. Riley FBR analyst David Buck upgraded Amag Pharmaceuticals to Buy from Neutral after the company agreed to sell Cord Blood Registry to private equity firm GI Partners for $530M in cash. The divestiture should allow the company to retire senior debt and become net debt free, which would eliminate his concern about Amag being highly-leveraged, Buck tells investors. Despite the "negative optics" of selling for below the $700M it paid to buy CBR, Buck sees the choice to divest as strategically sound, the analyst added. He raised his price target on Amag shares to $30 from $23, citing switching to Makena auto-injector, growth for Intrarosa and an early 2019 FDA approval for bremalanotide as key catalysts.
06/25/18
PIPR
06/25/18
NO CHANGE
Target $20
PIPR
Neutral
Piper Jaffray remains on sidelines after AMAG indicates launch of generic Makena
Piper Jaffray analyst Christopher Raymond maintained a Neutral rating and $20 price target on AMAG Pharmaceuticals after the company announced this morning that it intends to launch an authorized generic of Makena through generic manufacturer Prasco Laboratories, adding that Makena's loss of exclusivity "is now upon us." While he contends that the timing of the generic's approval "should surprise nobody," Raymond says this serves as a reminder to investors that a key threat to the business is now underway and remains on the sidelines. The analyst continues to model Makena revenue of $302M, $178M, $92M, and $29M for 2018-2021, adding that "the trajectory doesn't look pretty."

TODAY'S FREE FLY STORIES

INFY

Infosys

$10.22

0.32 (3.23%)

05:17
10/17/18
10/17
05:17
10/17/18
05:17
Recommendations
Infosys analyst commentary  »

Berenberg sees 30%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

TECH

Bio-Techne

$185.40

2.84 (1.56%)

05:13
10/17/18
10/17
05:13
10/17/18
05:13
Initiation
Bio-Techne initiated  »

Bio-Techne initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

BIO

Bio-Rad

$289.60

11.73 (4.22%)

05:12
10/17/18
10/17
05:12
10/17/18
05:12
Initiation
Bio-Rad initiated  »

Bio-Rad initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 01

    Nov

  • 07

    Nov

PSTG

Pure Storage

$23.40

1.1 (4.93%)

, NTAP

NetApp

$77.98

2.63 (3.49%)

05:10
10/17/18
10/17
05:10
10/17/18
05:10
Upgrade
Pure Storage, NetApp rating change  »

Pure Storage upgraded to…

PSTG

Pure Storage

$23.40

1.1 (4.93%)

NTAP

NetApp

$77.98

2.63 (3.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

NTAP

NetApp

$77.98

2.63 (3.49%)

05:08
10/17/18
10/17
05:08
10/17/18
05:08
Upgrade
NetApp rating change  »

NetApp upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

UAL

United Continental

$83.51

2.17 (2.67%)

05:04
10/17/18
10/17
05:04
10/17/18
05:04
Upgrade
United Continental rating change  »

United Continental…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

ANZFF

Air New Zealand

$0.00

(0.00%)

05:01
10/17/18
10/17
05:01
10/17/18
05:01
Upgrade
Air New Zealand rating change  »

Air New Zealand upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DAL

Delta Air Lines

$53.11

1.27 (2.45%)

04:59
10/17/18
10/17
04:59
10/17/18
04:59
Upgrade
Delta Air Lines rating change  »

Delta Air Lines upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

AAL

American Airlines

$33.30

1.52 (4.78%)

04:58
10/17/18
10/17
04:58
10/17/18
04:58
Upgrade
American Airlines rating change  »

American Airlines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

INFY

Infosys

$10.22

0.32 (3.23%)

04:55
10/17/18
10/17
04:55
10/17/18
04:55
Downgrade
Infosys rating change  »

Infosys downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

04:55
10/17/18
10/17
04:55
10/17/18
04:55
Conference/Events
Cowen healthcare analysts to hold an analyst/industry conference call »

Healthcare Analysts,…

SPLP

Steel Partners

$16.74

(0.00%)

04:55
10/17/18
10/17
04:55
10/17/18
04:55
Conference/Events
Steel Partners management to meet with Roth Capital »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

CYTK

Cytokinetics

$8.68

1.06 (13.91%)

04:55
10/17/18
10/17
04:55
10/17/18
04:55
Conference/Events
Cytokinetics management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 18

    Oct

  • 27

    Nov

SAIC

SAIC

$74.26

2.09 (2.90%)

04:55
10/17/18
10/17
04:55
10/17/18
04:55
Conference/Events
SAIC management to meet with SunTrust »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

LTS

Ladenburg Thalmann

$2.89

0.24 (9.06%)

04:55
10/17/18
10/17
04:55
10/17/18
04:55
Conference/Events
Ladenburg Thalmann management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

LGND

Ligand

$210.86

10.8 (5.40%)

04:55
10/17/18
10/17
04:55
10/17/18
04:55
Conference/Events
Ligand management to meet with Craig Hallum »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 18

    Oct

  • 06

    Nov

04:55
10/17/18
10/17
04:55
10/17/18
04:55
General news
Breaking General news story  »

Week of 10/12 MBA…

NSSC

NAPCO Security

$14.13

0.51 (3.74%)

04:55
10/17/18
10/17
04:55
10/17/18
04:55
Conference/Events
NAPCO Security management to meet with Benchmark »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 29

    Nov

AGLE

Aeglea BioTherapeutics

$10.04

0.6 (6.36%)

04:55
10/17/18
10/17
04:55
10/17/18
04:55
Conference/Events
Aeglea BioTherapeutics to hold a conference call »

Management provides an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

AGTC

Applied Genetic

$6.78

0.04 (0.59%)

04:55
10/17/18
10/17
04:55
10/17/18
04:55
Conference/Events
Applied Genetic management to meet with Wedbush »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

TRN

Trinity Industries

$37.12

0.4 (1.09%)

04:55
10/17/18
10/17
04:55
10/17/18
04:55
Conference/Events
Trinity Industries management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 25

    Oct

OKTA

Okta

$61.89

3.66 (6.29%)

04:55
10/17/18
10/17
04:55
10/17/18
04:55
Conference/Events
Okta management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

04:55
10/17/18
10/17
04:55
10/17/18
04:55
Conference/Events
Stephens restaurants analyst to hold a luncheon meeting »

Restaurants Analyst…

04:55
10/17/18
10/17
04:55
10/17/18
04:55
Conference/Events
RBC Capital IT services & payments analyst to hold luncheon meeting »

IT Services &…

04:55
10/17/18
10/17
04:55
10/17/18
04:55
General news
Housing Starts to be reported at 08:30 »

September Housing Starts…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.